BVFL logo

BVFL
BV Financial Inc (MD)

19
Mkt Cap
$175.01M
Volume
19,073.00
52W High
$20.54
52W Low
$14.05
PE Ratio
14.45
BVFL Fundamentals
Price
$20.00
Prev Close
$19.77
Open
$19.72
50D MA
$19.38
Beta
0.45
Avg. Volume
15,516.47
EPS (Annual)
$1.43
P/B
0.95
Rev/Employee
$514,254.90
$201.70
Loading...
Loading...
News
all
press releases
BV Financial (NASDAQ:BVFL) Upgraded by Wall Street Zen to "Buy" Rating
Wall Street Zen raised BV Financial from a 'hold' rating to a 'buy' rating in a research report on Saturday...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Insider Selling: BV Financial (NASDAQ:BVFL) Director Sells 6,000 Shares of Stock
BV Financial, Inc. (NASDAQ:BVFL - Get Free Report) Director Joseph Galli sold 6,000 shares of the stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an average price...
MarketBeat·9d ago
News Placeholder
Joseph Galli Sells 6,000 Shares of BV Financial (NASDAQ:BVFL) Stock
BV Financial, Inc. (NASDAQ:BVFL - Get Free Report) Director Joseph Galli sold 6,000 shares of BV Financial stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an...
MarketBeat·10d ago
News Placeholder
BV Financial Stock Falls 2% as March Quarter's Earnings Fall Y/Y
BVFL's March-end quarter's earnings drop y/y due to a CEO exit payout, though core income improves and margins expand amid stable balance sheet trends.
Zacks·10d ago
News Placeholder
BV Financial (NASDAQ:BVFL) Issues Earnings Results
BV Financial (NASDAQ:BVFL - Get Free Report) released its quarterly earnings data on Friday. The company reported $0.40 earnings per share (EPS) for the quarter. BV Financial had a return on equity...
MarketBeat·16d ago
News Placeholder
The Zacks Analyst Blog Highlights AstraZeneca, HSBC, Walt Disney, Oak Valley Bancorp and BV Financial
AstraZeneca (AZN) leads Zacks Research highlights with strong drug growth and pipeline momentum, while HSBC and Disney navigate costs and competition.
Zacks·1mo ago
News Placeholder
Top Research Reports for AstraZeneca, HSBC & Walt Disney
AstraZeneca's strong drug portfolio and pipeline fuel growth targets, while HSBC restructures and Disney balances streaming gains against rising costs.
Zacks·1mo ago
News Placeholder
BVFL Upgraded to Outperform on Asset Quality, Loan Growth
BV Financial's rating upgrade reflects improving asset quality, declining non-performing assets, strong capital and liquidity and steady expansion in higher-yielding commercial loans.
Zacks·1mo ago
News Placeholder
BV Financial, Inc. (NASDAQ:BVFL) Short Interest Update
BV Financial, Inc. (NASDAQ:BVFL - Get Free Report) saw a large increase in short interest in February. As of February 27th, there was short interest totaling 136,105 shares, an increase of 15.0% from...
MarketBeat·2mo ago
News Placeholder
BV Financial (OTCMKTS:BVFL) Stock Price Up 1.1% - Time to Buy?
BV Financial (OTCMKTS:BVFL) Trading Up 1.1% - Still a Buy...
MarketBeat·2mo ago
<
1
2
...
>

Latest BVFL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.